AQP4 and neuromyelitis optica: AQP1-Abs might potentially be a novel biomarker for AQP4-IgG seronegative NMOsd because of their presence in sera of some patients with demyelination in the CNS, abundant expression of AQP1 in astrocytes and similarities with AQP4-seronegative NMO [11].